{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-078295","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2022-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.742179+00:00","generated_at":"2026-06-26T22:02:16.594208+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Silverback Therapeutics Director Thilo Schroeder to not stand for re-election; resigns from audit committee","bullets":["Dr. Schroeder will not stand for re-election as Class II director at 2022 annual meeting.","He also resigned from the audit committee effective March 14, 2022.","Departure is not due to any dispute or disagreement with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-078295","json":"https://secwatch.observer/filing/0001193125-22-078295.json","markdown":"https://secwatch.observer/filing/0001193125-22-078295.md","text":"https://secwatch.observer/filing/0001193125-22-078295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522078295/0001193125-22-078295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522078295/d324895d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:02:16.594208+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"734d91298e","claim":"Thilo Schroeder departed as Director at ARS Pharmaceuticals, Inc..","evidence_excerpt":"On March 11, 2022, Thilo Schroeder, Ph.D. informed Silverback Therapeutics, Inc. (the “Company”) that he will not stand for re-election as a member of the Company’s board of directors when his term as a Class II director expires at the Company’s 2022 annual meeting of stockholders and on March 14, 2022, Dr. Schroeder resigned as a member of the audit committee of the board of directors of the Company (the “Audit Committee”) to focus on other endeavors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522078295/0001193125-22-078295-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}